Colgate-Palmolive Co. Files 2023 Annual Report on Form 10-K

TL;DR

<b>Colgate-Palmolive Co. has filed its 2023 annual report (10-K) detailing its financial performance and business operations for the fiscal year ending December 31, 2023.</b>

AI Summary

COLGATE PALMOLIVE CO (CL) filed a Annual Report (10-K) with the SEC on February 15, 2024. Colgate-Palmolive Co. filed its 10-K report for the fiscal year ending December 31, 2023. The filing covers the period from January 1, 2023, to December 31, 2023. The company's principal executive offices are located at 300 Park Ave, New York, NY 10022. Colgate-Palmolive Co. is incorporated in Delaware. The Standard Industrial Classification code for the company is 2844 (Perfumes, Cosmetics & Other Toilet Preparations).

Why It Matters

For investors and stakeholders tracking COLGATE PALMOLIVE CO, this filing contains several important signals. This 10-K filing provides a comprehensive overview of Colgate-Palmolive's financial health, operational strategies, and risk factors for the past fiscal year, crucial for investors and analysts to assess the company's performance and outlook. The detailed financial statements and disclosures within this report are essential for understanding the company's revenue streams, profitability, debt levels, and overall market position within the consumer goods sector.

Risk Assessment

Risk Level: medium — COLGATE PALMOLIVE CO shows moderate risk based on this filing. The company operates in a highly competitive consumer goods market, facing risks related to brand loyalty, changing consumer preferences, and intense competition from both established players and emerging brands, which could impact sales and market share.

Analyst Insight

Investors should review the detailed financial statements and risk factors in the 10-K to assess Colgate-Palmolive's ability to maintain its market position and drive future growth amidst competitive pressures and evolving consumer demands.

Key Numbers

• 2844 — SIC Code (Standard Industrial Classification)
• 001-00644 — SEC File Number (SEC file number)
• 24643733 — Film Number (Film number)

Key Players & Entities

• COLGATE PALMOLIVE CO (company) — Filer name
• CL (company) — Ticker symbol
• 20231231 (date) — Fiscal year end
• 20240215 (date) — Filing date
• 300 PARK AVE (address) — Business address
• NEW YORK (location) — Business address city
• NY (location) — Business address state
• DE (location) — State of incorporation

FAQ

Industry Context

Colgate-Palmolive operates within the global consumer goods sector, specifically focusing on oral care, personal care, home care, and pet nutrition. The industry is characterized by strong brand recognition, extensive distribution networks, and evolving consumer preferences towards health and sustainability.

Regulatory Implications

As a publicly traded company, Colgate-Palmolive is subject to the regulations of the U.S. Securities and Exchange Commission (SEC), requiring regular filings such as this 10-K to ensure transparency and provide material information to investors.

What Investors Should Do

1. Analyze the detailed financial statements within the 10-K to understand revenue trends, cost structures, and profitability for FY2023.
2. Review the 'Risk Factors' section to identify potential challenges and management's strategies for mitigation.
3. Compare key financial metrics (if available in future filings or related documents) with industry peers to assess competitive positioning.

Key Dates

• 2023-12-31: Fiscal Year End — End of the reporting period for the 10-K filing.
• 2024-02-15: Filing Date — Date the 10-K report was officially submitted to the SEC.

Year-Over-Year Comparison

This filing is the annual report for the fiscal year ending December 31, 2023, and will be compared against previous filings to identify year-over-year changes in financial performance and business strategy.

Key Financial Figures

• $1.00 — ange on which registered Common Stock, $1.00 par value CL New York Stock Exchange 0

Filing Documents

• cl-20231231.htm (10-K) — 2917KB
• exhibit4a12312023.htm (EX-4) — 94KB
• exhibit2112312023.htm (EX-21) — 113KB
• exhibit2312312023.htm (EX-23) — 3KB
• exhibit2412312023.htm (EX-24) — 33KB
• exhibit31a12312023.htm (EX-31.A) — 9KB
• exhibit31b12312023.htm (EX-31.B) — 9KB
• exhibit3212312023.htm (EX-32) — 5KB
• exhibit9712312023.htm (EX-97) — 44KB
• cl-20231231_g1.jpg (GRAPHIC) — 161KB
• cl-20231231_g2.jpg (GRAPHIC) — 155KB
• cl-20231231_g3.jpg (GRAPHIC) — 118KB
• image_0.jpg (GRAPHIC) — 0KB
• 0000021665-24-000003.txt (&nbsp;) — 17178KB
• cl-20231231.xsd (EX-101.SCH) — 94KB
• cl-20231231_cal.xml (EX-101.CAL) — 142KB
• cl-20231231_def.xml (EX-101.DEF) — 496KB
• cl-20231231_lab.xml (EX-101.LAB) — 1210KB
• cl-20231231_pre.xml (EX-101.PRE) — 850KB
• cl-20231231_htm.xml (XML) — 3058KB

Page

Part I Page

Business 1

Item 1. Business 1

Risk Factors 7

Item 1A. Risk Factors 7

Unresolved Staff Comments 20

Item 1B. Unresolved Staff Comments 20

Cybersecurity 21

Item 1C. Cybersecurity 21

Properties 23

Item 2. Properties 23

Legal Proceedings 24

Item 3. Legal Proceedings 24

Mine Safety Disclosures 24

Item 4. Mine Safety Disclosures 24 Part II

Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 25

Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 25

[Reserved] 25

Item 6. [Reserved] 25

Management's Discussion and Analysis of Financial Condition and Results of Operations 26

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 26

Quantitative and Qualitative Disclosures About Market Risk 59

Item 7A. Quantitative and Qualitative Disclosures About Market Risk 59

Financial Statements and Supplementary Data 60

Item 8. Financial Statements and Supplementary Data 60

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 60

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 60

Controls and Procedures 60

Item 9A. Controls and Procedures 60

Other Information 60

Item 9B. Other Information 60

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 60

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 60 Part III

Directors, Executive Officers and Corporate Governance 61

Item 10. Directors, Executive Officers and Corporate Governance 61

Executive Compensation 61

Item 11. Executive Compensation 61

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 62

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 62

Certain Relationships and Related Transactions and Director Independence 62

Item 13. Certain Relationships and Related Transactions and Director Independence 62

Principal Accountant Fees and Services 62

Item 14. Principal Accountant Fees and Services 62 Part IV

Exhibits and Financial Statement Schedules 63

Item 15. Exhibits and Financial Statement Schedules 63

Form 10-K Summary 67

Item 16. Form 10-K Summary 67 Signatures 68 PART I

BUSINESS

ITEM 1. BUSINESS General Development of the Business Colgate-Palmolive Company (together with its subsidiaries, "we," "us," "our," the "Company" or "Colgate") is a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet. We seek to deliver sustainable, profitable growth and superior shareholder returns, as well as provide Colgate people with an innovative and inclusive work environment. We do this by developing and selling science-led products globally that make people's and their pets' lives healthier and more enjoyable and by embracing our sustainability and social impact and diversity, equity and inclusion ("DE&I") strategies across our organization. Our products are marketed in over 200 countries and territories throughout the world. Colgate was founded in 1806 and incorporated under the laws of the State of Delaware in 1923. For recent business developments and other information, refer to the information set forth under the captions "Management's Discussion and Analysis of Financial Condition and Results of Operations–Executive Overview," "– Outlook," "–Results of Operations" and "– Liquidity and Capital Resources" in Part II, Item 7 of this report. Description of the Business We operate in two product segments: Oral, Personal and Home Care; and Pet Nutrition. We are a leader in Oral Care with global leadership in the toothpaste and manual toothbrush categories according to market share data. We sell our toothpastes under brands such as Colgate, Darlie, elmex, hello, meridol, Sorriso and Tom's of Maine, our toothbrushes under brands such as Colgate, Darlie, elmex and meridol and our mouthwashes under brands such as Colgate, elmex and meridol. Our Oral Care business also includes pharmaceutical products for dentists and other oral health professionals. We are a leader in many product categories of the Personal Care market with global leadership in liquid hand soap, according to market share data, whi